This would be terrific, but I think the first step would be to get T36 past the clinical trials for a topical agent. This should be far less costly and much faster to get through vs. something injected or taking internally. I've been waiting for TO to release some guidance or at least updates to what has happened since the FDA approval. I would have liked to see some sort of joint venture with another more established pharamaceutical company to help break into the disinfecting and therapeutic markets in the USA.

The share price is tanking to new depths, and will continue to do so with managements laissez-faire attitude, or at least this is how it appears to shareholders. It is quiet around here because I fear that many shareholders have capitulated on the incompetance and betrayal of management.